lovastatin has been researched along with Cirrhosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, L; Li, R; Lu, Q; Lu, S; Lyu, L; Ma, Z; Xu, H | 1 |
| Chen, Z; Duan, Q; Gong, L; Liu, Z; Wu, P; Xia, F; Yang, T; Zhao, T; Zheng, Z | 1 |
| Bulik, II; Khil'ko, IuA; Kravchenko, DA; Medvetskiĭ, EB; Nichitaĭlo, ME; Savitskaia, IM; Shpon'ka, IS | 1 |
| Brand, M; Fritz, G; Henninger, C; Huelsenbeck, J; Huelsenbeck, S; Schad, A; Wenzel, P | 1 |
| Drukker, A; Eddy, AA | 1 |
| Bitterman, PB; Dahm, C; Levrey, H; Polunovsky, VA; Rubins, J; Tan, A | 1 |
6 other study(ies) available for lovastatin and Cirrhosis
| Article | Year |
|---|---|
Renal Resistive Index as a Novel Indicator for Renal Complications in High-Fat Diet-Fed Mice.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, High-Fat; Fibrosis; Glomerular Filtration Rate; Kidney; Lovastatin; Male; Mice; Mice, Inbred C57BL; Renal Artery; Ultrasonography | 2017 |
Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cell Cycle Proteins; Cell Line; Fibrosis; Lovastatin; Male; Mice, Inbred C57BL; Myocardium; Signal Transduction; Trans-Activators; YAP-Signaling Proteins | 2019 |
[Inhibition of the stellate cells using lisinopril and lovastatin for prophylaxis of pancreatic stump fibrosis after performance of distal resection in a model of chronic alcoholic pancreatitis].
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Desmin; Female; Fibrosis; Gene Expression; Glial Fibrillary Acidic Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Lovastatin; Matrix Metalloproteinase 1; Pancreas; Pancreatectomy; Pancreatic Stellate Cells; Pancreatitis, Alcoholic; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-2; Vimentin | 2013 |
Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Connective Tissue Growth Factor; DNA Damage; DNA, Mitochondrial; Doxorubicin; Female; Fibrosis; Gene Expression Profiling; HSP70 Heat-Shock Proteins; Interleukin-6; Lovastatin; Mice, Inbred C57BL; Myocardium; Natriuretic Peptide, Brain | 2015 |
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Collagen; Female; Fibronectins; Fibrosis; Kidney; Lipid Peroxides; Lipoproteins, LDL; Liver; Lovastatin; Macrophages; Microscopy, Fluorescence; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta; Treatment Failure; Vitamin E | 1998 |
Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders.
Topics: Animals; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Granulation Tissue; Guinea Pigs; Humans; Lovastatin; Lung; Mevalonic Acid; Protein Processing, Post-Translational; Pulmonary Fibrosis; ras Proteins; Reference Values; Wound Healing | 1999 |